Prognosis and Outcomes for Endocrine Resistant Versus Endocrine Sensitive Patients with Metastatic Breast Cancer
Breast cancer remains the leading cause of death for women in South America, the Middle East, and most of Europe1. 90% of breast cancer deaths are caused by metastatic disease, in which the cancer spreads to other parts of the body or recurs at a distant site. Between 20 and 30% of patients diagnosed with primary breast cancer will develop metastatic disease.2 Unfortunately, metastatic breast cancer cannot currently be cured but it is treated to prevent the cancer cells spreading further and extend a patient's life.
No hay comentarios:
Publicar un comentario